is retatrutide a glp-3 What GLP‑3 Really Is: Triple‑Receptor Drug GLP3 Weight Loss: What Retatrutide

13 Although evidence suggests that GLP-1 RAs may have neuroprotective properties and delay disease progression, this was based on a few small phase II studies

Many plans additionally require a trial of a preferred alternative agent and documented follow-up with demonstrated response for continued authorization

There is no confirmed UK launch date for retatrutide

Injections are once a week

The regain problem The main theory for why the majority of patients regain weight so rapidly when they stop taking medication is because the regions of the brain relating to appetite are still dysregulated, priming the person to overconsume